Aliases & Classifications for Cleft Lip

About this section

Aliases & Descriptions for Cleft Lip:

Name: Cleft Lip 10 47 12 36
Cleft Lip, Unilateral, Complete 10
Complete Unilateral Cleft Lip 10
 
Labium Leporinum 10
Cheiloschisis 10
Hare Lip 10

Classifications:



External Ids:

Disease Ontology10 DOID:9296
ICD1027 Q36, Q36.9
MeSH36 D002971
NCIt42 C87175
UMLS65 C0008924, C0158651

Summaries for Cleft Lip

About this section
MalaCards based summary: Cleft Lip, also known as cleft lip, unilateral, complete, is related to cleft lip, congenital healed and cleft lip/palate-ectodermal dysplasia syndrome. An important gene associated with Cleft Lip is MSX1 (Msh Homeobox 1), and among its related pathways are TP53 network and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include bone, liver and brain, and related mouse phenotypes are respiratory system and muscle.

Related Diseases for Cleft Lip

About this section

Diseases related to Cleft Lip via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 705)
idRelated DiseaseScoreTop Affiliating Genes
1cleft lip, congenital healed33.8MTHFR, PHF8, TP63
2cleft lip/palate-ectodermal dysplasia syndrome12.6
3ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 312.6
4cleft lip +/- cleft palate12.6
5coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation12.5
6median cleft lip/mandibule12.5
7arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay12.5
8coloboma, cleft lip/palate and mental retardation syndrome12.5
9polydactyly cleft lip palate psychomotor retardation12.4
10ectrodactyly and ectodermal dysplasia without cleft lip/palate12.4
11ectropion inferior cleft lip and or palate12.4
12microbrachycephaly ptosis cleft lip12.4
13microcephaly, corpus callosum dysgenesis and cleft lip-palate12.4
14amelia cleft lip palate hydrocephalus iris coloboma12.3
15anophthalmia cleft lip palate hypothalamic disorder12.3
16cleft lip and palate malrotation cardiopathy12.3
17cleft lip and/or palate with mucous cysts of lower12.3
18cleft lip palate dysmorphism kumar type12.3
19cleft lip palate mental retardation corneal opacity12.3
20cleft lip palate oligodontia syndactyly pili torti12.3
21cleft lip palate pituitary deficiency12.3
22cleft lip palate-tetraphocomelia12.3
23craniosynostosis cleft lip palate arthrogryposis12.3
24holoprosencephaly ectrodactyly cleft lip palate12.3
25hypopituitarism micropenis cleft lip palate12.3
26lagophthalmia cleft lip palate12.3
27multiple congenital anomalies mental retardation, growth failure and cleft lip palate12.3
28syndactyly ectodermal dysplasia cleft lip palate hand foot12.3
29tibial hemimelia cleft lip palate12.3
30uveal coloboma-cleft lip and palate-intellectual disability12.3
31cleft lip/palate-deafness-sacral lipoma syndrome12.3
32cleft lip/palate-intestinal malrotation-cardiopathy syndrome12.3
33cleft lip-retinopathy syndrome12.3
34short stature-intellectual disability-eye anomalies-cleft lip/palate syndrome12.3
35auriculoocular anomalies-cleft lip syndrome12.3
36auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome12.3
37orofacial cleft 1112.3
38hay-wells syndrome12.0
39rapp-hodgkin syndrome12.0
40van der woude syndrome12.0
41eec syndrome11.9
42vici syndrome11.9
43stickler syndrome11.9
44orofacial cleft 611.9
45orofacial cleft 511.9
46branchiooculofacial syndrome11.9
47popliteal pterygium syndrome 111.8
48orofacial cleft 1011.8
49hartsfield syndrome11.8
50roberts syndrome11.8

Graphical network of the top 20 diseases related to Cleft Lip:



Diseases related to cleft lip

Symptoms for Cleft Lip

About this section

Drugs & Therapeutics for Cleft Lip

About this section

Drugs for Cleft Lip (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 70)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AmoxicillinapprovedPhase 439126787-78-033613, 2171
Synonyms:
(-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid
(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26787-78-0
33911-69-2
34642-77-8 (mono-hydrochloride salt)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI)
6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid
6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin
6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid
6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid
6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid
6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI
61336-70-7 (TRIHYDRATE)
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl
6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
71447-36-4
81030-75-3
AC-12263
AC1L1PY2
AMC
AMOXICILLIN CRYSTALLINE
AMOXICILLIN PEDIATRIC
AMPC
AUGMENTIN '125'
AUGMENTIN '200'
AUGMENTIN '250'
AUGMENTIN '400'
AUGMENTIN '500'
AUGMENTIN '875'
AUGMENTIN ES-600
AX
Actimoxi
Almodan
Ambap26787-78-0
Amix
Amoclen
Amolin
Amopen
Amopenixin
Amoram
Amox
Amox 250 Cap 250mg
Amox 500 Cap 500mg
Amox S 125 Sus 125mg/5ml
Amox S 250 Sus 250mg/5ml
Amoxi
Amoxi-Mast
Amoxi-mast
Amoxibiotic
Amoxicaps
Amoxicilina
Amoxicilina [INN-Spanish]
Amoxicillin
Amoxicillin (INN)
Amoxicillin (TN)
Amoxicillin (anhydrous)
Amoxicillin (inn)
Amoxicillin Extended-release
Amoxicillin Trihydrate
Amoxicillin and clavulanate potassium
Amoxicillin anhydrous
Amoxicillin pediatric
Amoxicillin sodium
Amoxicillin trihydrate
Amoxicillin(usan)
Amoxicilline
Amoxicilline [INN-French]
Amoxicilline [INN]
Amoxicilline [inn]
Amoxicillinum
Amoxicillinum [INN-Latin]
Amoxid
Amoxiden
Amoxil
Amoxivet
Amoxycillin
Amoxycillin Trihydrate
Amoxycillin trihydrate
Amoxycillin, BAN
Amoxymed
Amrit
Anemolin
Apo-Amoxi
Apo-Amoxi Cap 250mg
Apo-Amoxi Cap 500mg
Apo-Amoxi Pwr for Susp 125mg/5ml
Apo-Amoxi Pwr for Susp 250mg/5ml
Apo-amoxi
Apo-amoxi sugar free
Aspenil
Augmentinxr
BL-P 1410
BLP 1410
BPBio1_000499
BRD-K55044200-001-03-9
BRL 2333
 
BRL-2333
BSPBio_000453
Biomox
Bristamox
C06827
CHEBI:2676
CHEBI:53712
CHEMBL1082
CID33613
CPD000058707
Cemoxin
Clamoxyl
Clamoxyl (SKB)
D-(-)-alpha-Amino-p-hydroxybenzyl penicillin
D-(-)-alpha-Amino-p-hydroxybenzylpenicillin
D-(alpha-Amino-p-hydroxybenzyl)penicillin
D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid
D-Amoxicillin
D07452
DB01060
Delacillin
DisperMox
Dispermox
EINECS 248-003-8
Efpenix
Flemoxin
Galenamox
Gen-Amoxicillin 250mg
Gen-Amoxicillin 500mg
HMS1569G15
HSDB 3204
Hiconcil
Histocillin
Hydroxyampicillin
Ibiamox
Imacillin
LS-149721
Lamoxy
Larotid
MLS000028632
MLS002222248
Metafarma capsules
Metifarma capsules
MolPort-003-981-182
MolPort-005-933-687
Moxacin
Moxal
Moxatag
NCGC00179554-01
NSC 277174
NSC277174
Novamoxin
Novamoxin Cap 250mg
Novamoxin Cap 500mg
Novamoxin Sus 125mg/5ml
Novamoxin Sus 250mg/5ml
Nu-Amoxi Cap 250mg
Nu-Amoxi Cap 500mg
Nu-Amoxi Sus 125/5ml
Nu-Amoxi Sus 250mg/5ml
Ospamox
P-Hydroxyampicillin
PHL-amoxicillin
PMS-amoxicillin
Pamoxicillin
Piramox
Polymox
Prestwick0_000357
Prestwick1_000357
Prestwick2_000357
Prestwick3_000357
Prestwick_713
Prevpac
Pro Amox Pwr for Oral Susp 125mg/5ml
Pro Amox-250 Cap 250mg
Pro Amox-500 Cap 500mg
Pro-Amox-250 Orl Sus 250mg/5ml
R-Hydroxyampicillin
Rimoxallin
Ro 10-8756
Robamox
SAM002264592
SMR000058707
SPBio_002374
Sauracillin
Sawamox PM
Sumox
Tolodina
Trimox
Unicillin
Utimox
Vetramox
Wymox
Zimox
alpha-Amino-p-hydroxybenzylpenicillin
alpha-amino-P-Hydroxybenzylpenicillin
amoxicillanyl
amoxicillin
p-Hydroxyampicillin
α-amino-p-hydroxybenzylpenicillin
2Anti-Infective AgentsPhase 4, Phase 2, Phase 117220
3Anti-Bacterial AgentsPhase 4, Phase 19140
4Antibiotics, AntitubercularPhase 4, Phase 15971
5Antitubercular AgentsPhase 41061
6
Fentanylapproved, illicit, investigationalPhase 3705437-38-73345
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
437-38-7
5-22-08-00049 (Beilstein Handbook Reference)
80832-90-2
990-73-8 (citrate)
AC1L1FQ2
Abstral
Actiq
BIDD:GT0555
BRN 0494484
CHEBI:119915
CHEMBL596
CID3345
D00320
DB00813
Duragesic
Duragesic (TN)
Duragesic-100
Duragesic-12
Duragesic-25
Duragesic-50
Duragesic-75
Durogesic
EINECS 207-113-6
Fentanest
Fentanil
Fentanil [DCIT]
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl (JAN/USAN/INN)
Fentanyl - Novaplus
Fentanyl Citrate
Fentanyl [INN:BAN]
Fentanyl citrate
Fentanyl-100
 
Fentanyl-12
Fentanyl-25
Fentanyl-50
Fentanyl-75
Fentanylum
Fentanylum [INN-Latin]
HSDB 3329
IONSYS
JNS020QD
L001275
LS-124439
Lazanda
Matrifen
MolPort-003-847-369
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-phenethylpiperidin-4-yl)-N-phenylpropanamide
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
NCGC00168252-01
Nasalfent
Oprea1_152073
Oprea1_207148
PDSP1_000860
PDSP2_000846
Pentanyl
Phentanyl
Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)- (9CI)
R 4263
Rapinyl
Sentonil
Sublimase
Sublimaze
Subsys
UNII-UF599785JZ
fentanyl
7
KetamineapprovedPhase 2, Phase 34676740-88-13821
Synonyms:
(+-)-Ketamine
(+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
(+/-)-Ketamine
(-)-Ketamine
(S)-(-)-Ketamine
(S)-Ketamine
(±)-ketamine
100477-72-3
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone
2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone
33643-45-7
6740-88-1
79499-51-7
AC1L1GSH
AC1Q40UR
AKOS001053247
BRN 2216965
C07525
C13H16ClNO
CHEBI:138833
CHEBI:6121
CHEMBL742
CI 581 base
CI-581
CID3821
CLSTA 20
Calypsol
Cetamina
Cetamina [INN-Spanish]
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)- (9CI)
Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)- (9CI)
Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)- (8CI)
D08098
DB01221
DEA No. 7285
DL-ketamine
 
DivK1c_000217
EINECS 229-804-1
Esketamine
Green
IDI1_000217
KBio1_000217
KETAMINE
KETAMINE HCL
Ketaject
Ketalar
Ketalar base
Ketamina
Ketamine (INN)
Ketamine Base
Ketamine HCL
Ketamine Hydrochloride
Ketamine [INN:BAN]
Ketamine hydrochloride
Ketaminum
Ketaminum [INN-Latin]
Ketanest
Ketoject
Ketolar
L-Ketamine
LS-57301
MLS001331674
MolPort-001-838-070
NCGC00159480-02
NCGC00159480-03
NINDS_000217
NMDA
NSC 70151
NSC70151
SMR000238141
Special K
Special K [street name]
Special k
T385
Tekam
Tekam (TN)
UNII-690G0D6V8H
dl-Ketamine
ketamine
l-Ketamine
8
Bupivacaineapproved, investigationalPhase 2, Phase 39642180-92-92474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Hydrochloride
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
DepoBupivacaine
 
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
Exparel
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Racemic bupivacaine
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Vivacaine
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
9
Folic Acidapproved, nutraceuticalPhase 3292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
10
AcetylcholineexperimentalPhase 3, Phase 1, Phase 268951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
11Central Nervous System DepressantsPhase 3, Phase 210016
12Anesthetics, IntravenousPhase 3, Phase 21943
13Anesthetics, GeneralPhase 3, Phase 22274
14Peripheral Nervous System AgentsPhase 3, Phase 2, Phase 118510
15NarcoticsPhase 32709
16Liver ExtractsPhase 3, Phase 2, Phase 13572
17pancreatic polypeptidePhase 320
18Analgesics, OpioidPhase 32304
19AnestheticsPhase 3, Phase 27385
20MicronutrientsPhase 33901
21HematinicsPhase 31121
22Vitamin B ComplexPhase 32847
23Trace ElementsPhase 33900
24VitaminsPhase 33857
25AnalgesicsPhase 3, Phase 29358
26Excitatory Amino AcidsPhase 2, Phase 31109
27Neurotransmitter AgentsPhase 3, Phase 2, Phase 114795
28Anesthetics, DissociativePhase 2, Phase 3417
29Anesthetics, LocalPhase 2, Phase 32347
30Excitatory Amino Acid AntagonistsPhase 2, Phase 31095
31Neuromuscular AgentsPhase 3, Phase 1, Phase 2922
32OnabotulinumtoxinAPhase 3, Phase 1, Phase 2588
33AbobotulinumtoxinAPhase 3, Phase 1, Phase 2588
34IncobotulinumtoxinAPhase 3, Phase 1, Phase 2599
35Botulinum ToxinsPhase 3, Phase 1, Phase 2616
36Botulinum Toxins, Type APhase 3, Phase 1, Phase 2588
37Cholinergic AgentsPhase 3, Phase 1, Phase 23243
38Folinic AcidNutraceuticalPhase 32604
39FolateNutraceuticalPhase 32924
40Vitamin B9NutraceuticalPhase 32924
41ColaNutraceuticalPhase 3, Phase 2, Phase 11768
42
IndinavirapprovedPhase 2110150378-17-95362440
Synonyms:
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide
(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
150378-17-9
157810-81-6
157810-81-6 (sulfate (1:1) (salt))
166746-42-5
1c6y
1hsg
1hsh
1k6c
1sdt
1sdu
1sdv
1sgu
216884-06-9
2avo
2avs
2avv
2bpx
AC-20034
AC1L1U7I
AKOS000280989
BIDD:GT0378
BIDD:PXR0141
C07051
 
C36H47N5O4
CHEBI:44032
Compound J
Crixivan
Crixivan (TM)
DB00224
IDV
Indinavir
Indinavir (*1:1 Sulfate salt*)
Indinavir [USAN]
Indinavir sulfate
Indinavir sulphate
Indinavir, Sulfate (1:1)
L 735524
L-735 524
L-735,524
L-735524
LS-173382
MK-639
MolPort-000-883-804
N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
NCGC00159460-02
NSC697197
Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide
Propolis+Indinavir
RS-253
UNII-9MG78X43ZT
indinavir
43
Ritonavirapproved, investigationalPhase 2850155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
44HIV Protease InhibitorsPhase 24558
45Protease InhibitorsPhase 24558
46Cytochrome P-450 Enzyme InhibitorsPhase 23036
47Anti-Retroviral AgentsPhase 22794
48Antiviral AgentsPhase 28071
49Cytochrome P-450 CYP3A InhibitorsPhase 21421
50
Doxorubicinapproved, investigationalPhase 1158223214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5

Interventional clinical trials:

(show all 47)
idNameStatusNCT IDPhase
1The Role of Antibiotic Prophylaxis in Cleft Palate and Velopharyngeal Insufficiency RepairNot yet recruitingNCT02688634Phase 4
2Assessing the Results of Lip Surgery in Patients With Cleft Lip and PalateCompletedNCT00070811Phase 2, Phase 3
3Oral Cleft Prevention Trial in BrazilCompletedNCT00098319Phase 3
4Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainCompletedNCT00538850Phase 3
5Botulinum Toxin to Improve Results in Cleft Lip RepairRecruitingNCT01429402Phase 3
6Infra-orbital Nerve Block for Post Operative Analgesia in Children Undergoing Cleft Lip Surgery.RecruitingNCT02514980Phase 2, Phase 3
7Oral Cleft Prevention ProgramActive, not recruitingNCT00397917Phase 3
8Cleft Palate Surgery and Speech DevelopmentCompletedNCT00004639Phase 2
9Cleft Orthognathic Surgery Versus Distraction Osteogenesis - Which is Better?CompletedNCT00930124Phase 2
10Improvement of the Appearance of Cleft Lip Scars Using BotoxRecruitingNCT02247193Phase 1, Phase 2
11External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesRecruitingNCT00637637Phase 2
12Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced CancerCompletedNCT00045006Phase 1
13Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerCompletedNCT00036790Phase 1
14MS-275 in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00020579Phase 1
15Thalidomide and Docetaxel in Treating Patients With Advanced CancerCompletedNCT00049296Phase 1
16Articulation and Phonology in Children With Unilateral Cleft Lip and PalateCompletedNCT00829101
17A Study to Examine the Relationship Between Sleep Apnea and Cleft Lip/PalateCompletedNCT00156442
18Systematic Pediatric Care for Oral Clefts - South AmericaCompletedNCT00097149
19Primary Palatoplasty in Pediatric Patients - A Retrospective Review of Surgical OutcomesCompletedNCT01380171
20Tympanometric Analysis in Cleft PalateCompletedNCT01820689
21Svangerskap, Arv, og Miljo (Pregnancy, Heredity and Environment)CompletedNCT00340977
22Relational Development in Children With Cleft Lips and Palates: Influence of the Waiting Period Prior to the First Surgical Intervention and the Parents' Psychological Perception of the AbnormalityCompletedNCT00993993
23Positive Exposure: A Photography and Video Intervention for Individuals With Craniofacial DifferencesCompletedNCT00340964
24Sleep and Behavior in Children With Cleft PalateCompletedNCT01046591
25Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish PopulationCompletedNCT00341068
26Genetic Analysis of Fraser Syndrome and Fryns SyndromeCompletedNCT00032877
27Child's Adipose Cells: Capacity of Tissue RegenerationCompletedNCT02779205
28Study of the Experiences and Needs of Parents Continuing a Pregnancy Following a Prenatal Diagnosis of HolopresencephalyCompletedNCT00005016
29Child and Infant Learning ProjectCompletedNCT00077831
30Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520
31Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialCompletedNCT00904514
32Follow Ups of Parents With Infants With Cleft Lip and PalateRecruitingNCT02415361
33Biochemical and Histological Comparison of Nasal and Auricular Cartilage in the Fetus and Newborn With Cleft Lip CarrierRecruitingNCT02505360
34One-Piece Le Fort I Osteotomy Versus Segmental Le Fort I OsteotomyRecruitingNCT01871623
35FaceBase BiorepositoryRecruitingNCT01252264
363D Imaging of Hard and Soft Tissue in Orthognathic SurgeryRecruitingNCT00285714
37The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)RecruitingNCT01601171
38Susceptibility Genes in Autism Spectrum DisordersRecruitingNCT02628808
39Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate PatientsActive, not recruitingNCT01932164
40Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate PatientsActive, not recruitingNCT02329509
41Alveolar Bone Grafting Outcome Between Patient With and Without Orthodontic TreatmentActive, not recruitingNCT02454998
42Osteogenesis and Dental Eruption Through Electrical StimuliActive, not recruitingNCT00975208
43Comparison of Two Nasoalveolar Molding Techniques in Complete Unilateral Cleft Lip PatientEnrolling by invitationNCT01883726
44Prospective Data-collection System for the Comprehensive Appraisal of Cleft CareNot yet recruitingNCT02702869
45Functional Nasal Surgery at the Time of Le Fort I Osteotomy: A Prospective, Single-blind, Randomized TrialNot yet recruitingNCT01883687
46IAN Injury After BSSO in Oral CleftsNot yet recruitingNCT01875965
47TWIST Human Gene and Cleft Lips and PalatesTerminatedNCT00213889

Search NIH Clinical Center for Cleft Lip


Cochrane evidence based reviews: cleft lip

Genetic Tests for Cleft Lip

About this section

Anatomical Context for Cleft Lip

About this section

MalaCards organs/tissues related to Cleft Lip:

33
Bone, Liver, Brain, Breast, Lung, T cells, Prostate

Animal Models for Cleft Lip or affiliated genes

About this section

MGI Mouse Phenotypes related to Cleft Lip:

38 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053889.0BMP4, MSX1, PAX9, RARA, TFAP2A, TGFB3
2MP:00053699.0BMP4, FGFR1, MSX1, PAX9, RARA, TGFA
3MP:00053798.8BMP4, FGFR1, MSX1, PAX9, RARA, TFAP2A
4MP:00107718.7BMP4, FGFR1, IRF6, MSX1, MTHFR, NECTIN1
5MP:00053808.7BMP4, FGFR1, IRF6, MSX1, PAX9, RARA
6MP:00053778.5BMP4, FGFR1, IRF6, MSX1, PAX9, RARA
7MP:00028738.5BMP4, FGFR1, PAX9, RARA, SUMO1, TBX10
8MP:00053718.3BMP4, FGFR1, IRF6, MSX1, MTHFR, PAX9
9MP:00053917.9BMP4, FGFR1, MSX1, MTHFR, NECTIN1, RARA
10MP:00053907.8BMP4, FGFR1, IRF6, MSX1, MTHFR, PAX9
11MP:00053817.6BMP4, FGFR1, IRF6, MSX1, PAX9, RARA
12MP:00053827.3BMP4, FGFR1, IRF6, MSX1, NECTIN1, PAX9
13MP:00107687.1BMP4, FGFR1, IRF6, MSX1, MTHFR, NECTIN1
14MP:00053786.5BMP4, FGFR1, IRF6, MSX1, MTHFR, MTRR

Publications for Cleft Lip

About this section

Articles related to Cleft Lip:

(show top 50)    (show all 997)
idTitleAuthorsYear
1
Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich ataxia. (27079523)
2016
2
Analysis of the subcellular localization of the human histone methyltransferase SETDB1. (26296461)
2015
3
Acute Myocardial Infarction in a Young Lady due to Vitamin B12 Deficiency Induced Hyperhomocysteinemia. (25838876)
2015
4
Molecular analysis of a series of Israeli families with ComA"l-Netherton syndrome. (24577329)
2014
5
UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study. (23781580)
2013
6
Correlation of vascular endothelial growth factor expression with tumor recurrence and poor prognosis in patients with pN0 gastric cancer. (21773953)
2012
7
Oxaliplatin induced disseminated intravascular coagulation: A case report and review of literature. (22844549)
2012
8
Atherothrombosis in 2 vascular territories in a young woman: importance of thrombophilia testing. (20460352)
2011
9
Proteopedia entry: HMG-CoA reductase. (21433257)
2011
10
Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience. (21869678)
2011
11
Constrictive pericarditis with extensive calcification. (21308337)
2011
12
Review and update of mutations causing Waardenburg syndrome. (20127975)
2010
13
PSF1, a DNA replication factor expressed widely in stem and progenitor cells, drives tumorigenic and metastatic properties. (20103637)
2010
14
Correlation between expression of RhoA and Rho kinase in uterine smooth muscle and the onset of labor]. (19573309)
2009
15
Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: a retrospective, comparative study. (19660894)
2009
16
Profiling critical cancer gene mutations in clinical tumor samples. (19924296)
2009
17
Day-night variations of serum interleukin-6 in patients with severe obstructive sleep apnea syndrome before and after continuous positive airway pressure (CPAP). (18780208)
2008
18
Cutaneous angiosarcoma in a patient with xeroderma pigmentosum. (19008576)
2008
19
Associations between sympathetic activity, plasma concentrations of renin, aldosterone, and parathyroid hormone, and the degree of intractability of blood pressure control in modialysis patients. (17728496)
2007
20
Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplant. (17728847)
2007
21
Development of a novel bioavailable inhibitor of the calmodulin-regulated protein kinase MLCK: a lead compound that attenuates vascular leak. (16996151)
2006
22
p27Kip1 acts downstream of N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation. (15647380)
2005
23
S100A1 codistributes with synapsin I in discrete brain areas and inhibits the F-actin-bundling activity of synapsin I. (15147519)
2004
24
Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. (15187109)
2004
25
Inhibition of human breast cancer growth by GCP (genistein combined polysaccharide) in xenogeneic athymic mice: involvement of genistein biotransformation by beta-glucuronidase from tumor tissues. (12628503)
2003
26
Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade. (12675245)
2003
27
Genomic organization of the interleukin-1 locus. (11991723)
2002
28
Promising results in stomach cancer trial. (12217783)
2002
29
HLTF gene silencing in human colon cancer. (11904375)
2002
30
Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22. (11464283)
2001
31
Splenectomy during pregnancy: an option in treatment of autoimmune thrombocytopenic purpura. (10609737)
1999
32
Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. (9555728)
1998
33
Pick's disease: selective occurrence of apolipoprotein E-immunoreactive Pick bodies in the limbic system. (9452816)
1998
34
A Neisseria meningitidis fbpABC mutant is incapable of using nonheme iron for growth. (9573125)
1998
35
Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells. (9620593)
1998
36
Growth hormone-binding protein in normal and pathologic gestation: correlations with maternal diabetes and fetal growth. (9177400)
1997
37
Neurochemical coding in the small intestine of patients with Crohn's disease. (9245931)
1997
38
Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. (8040303)
1994
39
Syndrome of inappropriate antidiuretic hormone secretion in a patient with intrasellar neurofibroma of the sixth nerve. (1957525)
1991
40
Age-related changes in human D1 dopamine receptors measured by positron emission tomography. (1826059)
1991
41
Sonography in the diagnosis and management of acute acalculous cholecystitis. (3316013)
1987
42
Cloverleaf skull associated with Pfeiffer syndrome: pathology and management. (3792393)
1986
43
Mast cell degranulation in the evolution of acute eruptive guttate psoriasis vulgaris. (6512269)
1984
44
Birdshot chorioretinopathy: an etiological problem. (7343040)
1981
45
Solitary hyperfunctioning thyroid adenoma in a child. Elevated T3 and T4 levels with normal TSH level. (1242753)
1975
46
The story of Kwashiorkor. (12334431)
1973
47
Myxedema and myotonic dystrophy. (5008040)
1972
48
Asherman's syndrome. (5487746)
1970
49
METASTASIS OF THYROID TISSUE TO ABDOMINAL ORGANS: WITH SPECIAL CASE REPORT OF A STRUMA OVARII METASTASIZING TO THE OMENTUM. (17866434)
1930
50

Variations for Cleft Lip

About this section

Expression for genes affiliated with Cleft Lip

About this section
Search GEO for disease gene expression data for Cleft Lip.

Pathways for genes affiliated with Cleft Lip

About this section

GO Terms for genes affiliated with Cleft Lip

About this section

Biological processes related to Cleft Lip according to GeneCards Suite gene sharing:

(show all 23)
idNameGO IDScoreTop Affiliating Genes
1cloacal septationGO:006019710.7BMP4, TP63
2organ inductionGO:000175910.7BMP4, FGFR1
3regulation of odontogenesisGO:004248110.6MSX1, PAX9
4embryonic hindlimb morphogenesisGO:003511610.6BMP4, MSX1
5positive regulation of SMAD protein import into nucleusGO:006039110.6BMP4, TGFB3
6positive regulation of epithelial cell proliferationGO:005067910.6BMP4, TGFA
7salivary gland morphogenesisGO:000743510.4FGFR1, TGFB3
8wound healingGO:004206010.4BMP4, TGFA, TGFB3
9odontogenesisGO:004247610.4BMP4, MSX1, TGFB3
10prostate gland developmentGO:003085010.3RARA, TP63
11folic acid metabolic processGO:004665510.3MTHFR, MTRR
12face morphogenesisGO:006032510.3MSX1, PAX9, TGFB3
13regulation of cell differentiationGO:004559510.2BMP4, FGFR1, TFAP2A
14steroid hormone mediated signaling pathwayGO:004340110.2BMP4, RARA
15skeletal system developmentGO:000150110.2BMP4, FGFR1, TP63
16germ cell developmentGO:00072819.9BMP4, RARA
17anatomical structure formation involved in morphogenesisGO:00486469.8BMP4, TP63
18palate developmentGO:00600219.7MSX1, TFAP2A, TGFB3
19embryonic limb morphogenesisGO:00303269.7BMP4, FGFR1, MSX1, TP63
20negative regulation of apoptotic processGO:00430669.4BMP4, MSX1, RARA, TFAP2A, TP63
21negative regulation of transcription, DNA-templatedGO:00458929.4BMP4, MSX1, PAX9, RARA, TP63
22regulation of transcription, DNA-templatedGO:00063559.3IRF6, RARA, TBX10, TFAP2A, TP63
23positive regulation of transcription from RNA polymerase II promoterGO:00459449.2BMP4, PAX9, TFAP2A, TGFB3, TP63

Sources for Cleft Lip

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet